Showing results (221-230 of 479) with videos related to
Sort By:
Pageof 48
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 25, 2009
[Clinical significance of apolipoprotein B-48 (apoB-48) in patients with thyroid disease]Satomi Mugii, Hiroyuki Hanada, Keiko Takeoka, et al.Eye & Contact Lens|September 9, 2010
Transforming growth factor beta signal transduction: a potential target for maintenance/restoration of transparency of the corneaShizuya Saika, Osamu Yamanaka, Takayoshi Sumioka, et al.Case Reports in Ophthalmological Medicine|April 5, 2016
A Case of Solitary Nonvascularized Corneal Epithelial DysplasiaTomoya Morii, Takayoshi Sumioka, Ai Izutani-Kitano, et al.DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|May 20, 2000
Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genesE H Hurowitz, J M Melnyk, Y J Chen, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2019
Shp2-mediated MAPK pathway regulates ΔNp63 in epithelium to promote corneal innervation and homeostasisYuka Okada, Yujin Zhang, Lingling Zhang, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|November 17, 2020
Loss of sphingosine 1-phosphate receptor 3 gene function impairs injury-induced stromal angiogenesis in mouse corneaShingo Yasuda, Takayoshi Sumioka, Hiroki Iwanishi, et al.Journal of Lipid Research|December 22, 2006
Role of LCAT in HDL remodeling: investigation of LCAT deficiency statesBela F Asztalos, Ernst J Schaefer, Katalin V Horvath, et al.Experimental Eye Research|September 28, 2017
Ocular surface inflammation impairs structure and function of meibomian glandShin Mizoguchi, Hiroki Iwanishi, Reiko Arita, et al.Journal of Atherosclerosis and Thrombosis|February 9, 2018
Guidance for Pediatric Familial Hypercholesterolemia 2017Mariko Harada-Shiba, Takao Ohta, Akira Ohtake, et al.Atherosclerosis|April 11, 2016
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trialShun Ishibashi, Shizuya Yamashita, Hidenori Arai, et al.Pageof 48